← Open Payments lookup

NAMITHA KACHE: Open Payments

NPI 1770045171 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,874 in 150 payments from 18 companies in 2025. Trend: 2023 $1,149 · 2024 $1,511 · 2025 $3,874

Food & beverage: $3,770Education: $104
CompanyPaymentsAmount
Incyte Corporation23$570
GENZYME CORPORATION15$512
Galderma Laboratories, L.P.17$464
SUN PHARMACEUTICAL INDUSTRIES INC.21$406
Novartis Pharmaceuticals Corporation15$402
UCB, Inc.10$238
LEO Pharma Inc.8$233
Organon LLC8$169
ABBVIE INC.8$158
Regeneron Healthcare Solutions, Inc.7$143

Products named: DUPIXENT, Opzelura, NEMLUVIO, COSENTYX, ILUMYA, Bimzelx, ADBRY, VTAMA.

Industry payments across TX — which companies pay providers there.